{"nct_id":"NCT04526899","title":"A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-05","start_date":"2021-05-19","start_date_type":"ACTUAL","primary_completion_date":"2024-01-25","primary_completion_date_type":"ACTUAL","completion_date":"2025-12","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["BNTX"]}